Extended treatment of Cushing’s disease with pasireotide: results from a 2-year, Phase II study

Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations

(2013) Annamaria Colao et al.   Pituitary

MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects

(2012) R A Feelders et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Pasireotide in Cushing's Disease

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

(2012) Annamaria Colao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature

(2010) R. N. Clayton et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome

(2010) Rosario Pivonello et al.   NEUROENDOCRINOLOGY

Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas

(2010) Beverly MK Biller et al.   BMC Endocrine Disorders

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

(2009) Shlomo Melmed et al.   Pituitary

Hypopituitarism: Clinical Features, Diagnosis, and Management

(2008) Andrew A. Toogood et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement

(2008) B. M. K. Biller et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial

(2008) M. Boscaro et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM